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Serial Number

<:

#97-98--26

UNIVERSITY OF RHODE ISLAND
Kingston, Rhode Island
FACULTY SENATE
BILL
Adopted by the Faculty Senate
TO:
FROM:
1.

President Robert L. Carothers
Chairperson of the Faculty Senate
The attached BILL, titled The Three Hundred and Sixtieth Report
of the Curricular Affairs Committee:

Proposal for the 6-year

Doctor of Pharmacy Degree
is forwarded for your consideration.
2.

The original and two copies for your use are included.

3.

This BILL was adopted by vote of the Faculty Senate on
1998.

4.

After considering this bill, will you please indicate your approval
or disapproval. Return the original or forward it to the Board of
Governors, completing the appropriate endorsement below.

5.

In accordance with Section 10, paragraph 4 of the Senate's By-Laws,
this bill will become effective
May 14, 1998
, three weeks
after Senate approval, unless:
(1) specific dates for implementation
are written into the bill; (2) you return it disapproved; (3) you
forward it to the Board of Governors for their approval; or (4) the
University Faculty petitions for a referendum. If the bill is
forwarded to the Board of Governors, it will not become effective
until approved by the Board.
April 24, 1998
(date)

April 23,

eland Jackson
of the Faculty Senate

ENDORSEMENT
TO:
FROM:

Chairperson of the Faculty Senate
President of the University

Returned.
a.

Approved ~-

b.

Approved subject to final approval by Board of Governors

c.

Disapproved
( dat:e)

Form revised 9/91

~· .

UNIVERSITY OF RHODE ISLAND
Kingston, Rhode Island
FACULTY SENATE
March 31, 1998
Faculty Senate Curricular Affairs Committee
Three Hundred and Sixtieth Report
Proposal to Establish the 6-Year Doctor of Pharmacy Degree Program
As the Sole Professional Degree Offered by the
College of Pharmacy
At its meeting of March 30, 1998, the Curricular Affairs Committee
considered the proposal from the College of Pharmacy that begining
with students entering in the fall 1998 all students will follow a 6year curriculum for a degree of Pharm.D. which replaces the 5-year
Bachelors degree in Pharmacy and the existing 6-year Pharm.D. option.
The proposal is now presented to the Faculty Senate.

S E C T I 0 N

I

Background and Rationale
National professional standards for the practice of pharmacy have
changed over the past years. The American Council of Pharmaceutical
Education voted in 1996 that the Doctor of Pharmacy degree should be
the sole entry-level degree for the profession of pharmacy. The
University of Rhode Island College of Pharmacy voted in the fall of
1996 to phase out the Bachelor of Science degree in Pharmacy and
convert to an entry-level Doctor of Pharmacy degree with the freshman
class entering in the fall of 1998. currently, the College offers the
5-year B.S. degree and a track-in 6-year Doctor of Pharmacy degree
(students in the 4th year of the B.S. program apply for transfer into
the Pharm.D. program for their 5th and 6th years).
The following course deletions and additions represent a substantial
change in the professional curriculum years three through six for
students desiring to earn a pharmacy degree and thus to qualify to
practice pharmacy in Rhode Island and elsewhere. The College of
Pharmacy has worked over the past 18 months to create a new program of
study -- one that incorporates the new professional standards for
pharmacists, is integrated across disciplines in core areas of study,
provides space for professional electives, increases interactive
learning, provides skills to encourage self-instruction to promote
life-long learning, and meets accreditation standards for the practice
of pharmacy.
This proposed curriculum:
o meets all American Council of Pharmaceutical Education competency
standards for the year 2000;
o integrates complementary pharmacy courses by organ system (e.g.
the diseases of the central nervous system; and the pharmacology,
medicinal chemistry, and pharmacotherapeutics of drugs useful in
the treatment of these diseases are taught in the same semester) ;
o allows space for the student to elect professional coursework in
an area, or 'track', based on student interest;
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o uses interactive learning methods in small groups designed to
enhance communication and problem solving skills;
o streamlines required credits by eliminating two-tier didactic and
clincical courses which were previously needed for the two degree
programs, and
o through integration of coursework, avoids requiring students to
enroll in 18 and 19 credit semesters.
S E C T I 0 N

II

Matters Which Require Confirmation by the Faculty Senate.
A.

ADD: The following courses to be offered beginning in year 3
(2000-2001):
1.

Applied Pharmaceutical Sciences

a.

APS 314 Physical Pharmacy and Pharmaceutical
Calculations (I, 3) Physicochemical properties of
drug molecules, and their effect on formulation
and manufacturing of various dosage forms. An
emphasis on necessary pharmaceutical calculations.
(Lec.3)
Pre:
third year standing or permission
of instructor.
Zia

b.

APS 315 Biopharmaceutics (I, 2) Applications of
kinetics to dissolution, absorption, and other
biopharmaceutical processes.
Bioavailability and
generic equivalence. Regulatory aspects of
biopharmaceutics including special populations.
(Lee. 2) Pre:
third year standing or permission
of instructor. Rhodes

c.

APS 316 Pharmacy Law and Ethics (I, 3) Basic
principles of law and ethics as applied to
federal, state and local acts, regulation, and
practices encountered in professional practice.
Specific attention to liabilities of pharmacists
in decisions; actions involving sale of
medicinals, poisons, narcotics. (Lee. 3) Pre:
third year standing or permission of instructor.
Campbell

d.

APS 318 Pharmacy Technology Laboratory (I, 1)
Prescription processing and compounding techniques
for pharmaceutical dosage forms.
(Lab. 3) Pre:
third year standing or permission of instructor.
Zia

e.

APS 324 Pharmaceutical Technology (II, 3) A review
of the methods of manufacture of and eval uation of
drug delivery systems. (Lee. 3) Pre:
third year
standing or permission of instructor.
Kislalioglu
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2.

f.

APS 403 Pharmacokinetics I (I, 3) Pharmacokinetics
of drug distribution, metabolism, and elimination.
Compartmental models, pharmacokinetic modeling,
development of dosage regimens.
(Lee. 3) Pre:
fourth year standing or permission of instructor.
Rosenbaum

g.

APS 503 Health Systems I (I, 2) Introduction to
the principles of financial analysis, personal
management, organizational behavior, inventory
control, and health policy. Principles as they
relate to healthcare delivery with an emphasis on
planning systems.
(Lee. 2) Pre:
fifth year
standing or permission of instructor. Staff

h.

APS 504 Health Systems II (II, 3) Analysis and
interpretation of the health care delivery system
from the perspectives of organizational structure
and program analysis. Emphasis on
pharmacoeconomic aspects of quality of life
issues, outcome measurements, reimbursement
systems and drug utilization evaluation.
(Lee. 3)
Pre:
fifth year standing or permission of
instructor. Staff

Biomedical Sciences
a.

BMS 325 Principles of Drug Analysis (II, 2)
Competency in understanding the molecular basis of
drug analysis: neutralization,
oxidation/reduction, enzymatic reactions,
clinically relevant spectroscopic and
chromatographic techniques.
(Lee. 2) Pre: third
year standing or permission of instructor. Cho

b.

BMS 313 Introduction to Medicinal Chemistry and
Drug Metabolism (I,2) Basic chemical knowledge for
understanding drug-receptor interaction,
biotransformation of drugs [Phase I (oxidation,
reduct i on, hydrolysis) and Phase II (conjugation,
addition) metabolism], and prodrug concept.
(Lee.
2) Pre: third year standing or permission of
instructor. Cho, Panzica

c.

BMS 321 Principles of Pharmacology and Autonomic
Pharmacology (I,2) Fundamental principles of drug
action with emphasis on drug/receptor
interactions. Mechanisms of action and medicinal
chemistry of drugs that affect the autonomic
nervous system.
(Lee. 2) Pre: third year
standing or permission of instructor.
Babson,
Panzica and Rodgers
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d.

BMS 322 Pharmacology and Medicinal Chemistry of
Drugs Acting on the Central Nervous System (II,2)
Neurologic agents in the brain; antidepressants,
antipsychotics, sedative hypnotics, analgesics,
anti-seizure medications, anti-dementia therapy,
and anti-anxiety medications.
(Lee. 2) Pre:
third year standing or permission of instructor.
Swonger

e.

BMS 326 Pharmacology and Medicinal Chemistry
Laboratory I (II, 1) Effects of drugs on
physiological functions.
Identification and
quantification of drugs and their actions.
(Lab.
3) Pre: third year standing or permission of
instructor. Chichester, Cho and Staff

f.

BMS 416 Pharmacology and Medicinal Chemistry
Laboratory II (I, 1) Pharmacologic principles
relating to the modification of drug activity and
toxicity. Clinical assays relevant to assessing
drug effects.
(Lab. 3) Pre:
fourth year standing
or permission of instructor. Yan, Martin and
Staff

g.

BMS 421 Pharmacology and Medicinal Chemistry of
Anti-infective and Respiratory Agents (I, 2)
Chemistry, mechanism of action, sensitivity,
resistance and toxicity of anti-infections drugs,
and an overview of antibacterial, antifungal,
antiviral, antiprotozoal, respiratory drugs and
vaccines in current use.
(Lee. 2) Pre:
fourth
year standing or permission of instructor. Staff

h.

BMS 422 Endocrine, Gastrointestional and
Biotechnologic Drugs (II, 2) Mechanisms of action
of drugs used to treat endocrine and
gastrointestional disorders. Biological and
biotechnologic sources, isolation, design and
medicinal chemistry of biopolymer drugs.
(Lee. 2)
Pre: fourth year standing or permission of
instructor.
Babson and Martin

i.

BMS 521 Cancer Chemotherapy and Toxicology (I, 2)
Pharmacology and medicinal chemistry of oncology
drugs. Principles of toxicology.
(Lee. 2) Pre:
fifth year standing or permission of instructor.
Chichester, Panzica and Shaikh

j.

BMS 522 Pharmacology and Medicinal Chemistry of
Cardiovascular and Renal Drugs (II, 2) Mechanism
of action, adverse effects and therapeutic
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appl ications of drugs affecting cardiovascular and
renal function.
(Lee. 2) Pre:
fifth year
standing or permission of instructor. Rodgers
3.

Biomedical Sciences and Pharmacy Practice
a.

BMS 311 (or PHP 311) Foundations of Human Disease
I: Immunoinflammatory Disease (I, 2) The
pathogenesis, etiology, epidemiology, symptomatology, and diagnosis of immunoinflammatory and
musculo-skeletal diseases. The pharmacology and
medicinal chemistry of anti-inflammatory
medications, immunosuppressives, and
anti-rheumatic drugs.
(Lee. 2) Pre: third year
standing or permission of instructor. Chichester,
Panzica, Martin, Owens

b.

BMS 312 (or PHP 312) Foundations of Human Disease
II: Central Nervous System Disease (II, 2) The
etiology, pathogenesis, epidemiology, symptomatology, and diagnosis of diseases of the central
nervous system. (Lee. 2) Swonger, Owens

c.

BMS 411 (or PHP 411) Foundations o.f Human Disease
III: Infectious and Pulmonary Processes (I, 2)
The etiology, pathogenesis, epidemiology,
symptomatology, and diagnosis of infections and
pulmonary diseases.
(Lee. 2) Pre:
fourth year
standing or permission of instructor. Geletko,
Shimizu

d.

BMS 412 (or PHP 412) Foundations of Human Disease
IV: Endocrinology, Oncology, Medicinal Genetics,
GI (II, 3) The etiology, pathogenesis,
symptomatology, and disgnosis of diseases of
endocrine, oncologic, and genetic origin.
(Lee.
3) Pre:
fourth year standing or permission of
instructor. Yan, Glen

e.

BMS 512 (or PHP 512) Foundations of Human Disease
V: Renal and Cardiovascular Diseases (II, 2) The
etiology, pathogenesis, epidemiology, and
symptomatology, and diagnosis of renal and
cardiovascular diseases. (Lee. 2) Pre:
fifth year
standing or permission of instructor. Barbour
Rodgers

f.

BMS 518 (or PHP 518) Self-Care I (I, 3) An
overview of alternative therapies with an emphasis
on self-care and natural medicine alternatives.
Basic information as well as case studies.
(Lee.
3) Pre:
fifth year standing or permission of
instructor. Staff
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4.

Pharmacy Practice
a.

PHP 324 Pharmacotherapy of CNS and Musculoskeletal Disorders - Therapeutics I (II, 2) The
appropriate use of medications in the treatment of
human disease. Interpretation of clinical data to
design, monitor, and modify drug therapy in
psychiatric, neurologic, and musculo-skeletal
diseases.
(Lee. 2) Pre: third year standing or
permission of instructor. Dufresne

b.

PHP 413 Pharmacotherapy of Infectious Diseases Therapeutics II (I, 2) The appropriate use of
medications in the treatment of human disease.
Interpretation of clinical data to design,
monitor, and modify drug therapy in infection and
pulmonary disease.
(Lee. 2) Pre:
fourth year
standing or permission of instructor. Rana

c.

PHP 414 Pharmacotherapy of Endocrine and GI
Disorders - Therapeutics III (II, 2) The
appropriate use of medicatons in the treatment of
human disease.
Interpretation of clinical data to
design, monitor, and modify drug therapy in
endocrine and gastrointestinal disease. (Lee. 2)
Pre: fourth year standing or permission of
instructor. Luisi

d.

PHP 513 Pharmacotherapy of Oncology and Toxicology
- Therapeutics IV (I, 2) The appropriate use of
medications in the treatment of human disease.
Interpretation of clinical data to design,
monitor, and modify drug therapy in cancer, blood
disorders, and overdose conditions.
(Lee. 2) Pre:
fifth year standing or permission of instructor.
Glen

e.

PHP 514 Pharmacotherapy of Renal and
Cardiovascular Disorders - Therapeutics V (II, 2)
The appropriate use of medications in the
treatment of human disease.
Interpretation of
clinical data to design, monitor, and modify drug
therapy in renal and cardiovascular disease.
(Lee. 2) Pre:
fifth year standing or permission
of instructor. Hume

f.

PHP 591 Clinical Clerkship (I and II, 7) Through
direct clinical contact, students will learn how
to provide optimal pharmaceutical care for
patients. Students will collect and interpret
data to design, recommend, implement, and modify
patient-specific pharmacotherapy in collaboration
with other health care professionals.
(Practicum
7.5 wks) Pre: sixth year standing. Geletko and
Staff
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5.

g.

PHP 592 Clinical Clerkship (I and II, 7) Through
direct clinical contact, students Q~~l learn how
to provide optimal pharmaceuticall\fohatients.
students will collect and interpret data to
design, recommend, implement, and modify
patient-specific pharmacotherapy in collaboration
with other hea l th care professionals.
(Practicum
7.5 wks) Pre: sixth year standing. Geletko and
Staff

h.

PHP 593 Clinical Clerkship (I and II, 7) Through
direct clinical contact, students will learn how
to provide optimal pharmaceutical care for
patients. Students will collect and interpret
data to design, recommend, implement, and modify
patient-specif i c pharmacotherapy in collaboration
with other health care professionals.
(Practicum
7.5 wks) Pre: sixth year standing. Geletko and
Staff

Pharmacy
a.

PHC 317 Interactive Learning Session I (I, 1)
Small group active learning sessions designed to
progressively reinforce the basic science
curriculum, promote communication and
problem-solving skills, and enhance patient
assessment and the delivery of pharmaceutical
care.
(Seminar 1) Pre: third year standing or
permission of instructor. Staff

b.

PHC 327 Interactive Learning Session II (II, 1)
Small goup active learning designed to
progressively reinforce the basic science
curriculum, promote communication and
problem-solving skills, and enhance patient
assessment and the delivery of pharmaceutical
care.
(Seminar 1) Pre: third year standing or
permission of instructor. Staff

c.

PHC 417 Interactive Learning Session III (I, 1)
Small group active learning designed to
progressively reinforce the basic science
curriculum, promote communication and
problem-solving skills, and enhance patient
assessment and the delivery of pharmaceutical
care.
(Seminar 1) Pre:
fourth year standing or
permission of instructor. Staff

d.

PHC 427 Interactive Learning Session IV (II, 1)
Small group active learning designed to
progressively reinforce the basic II 8
science
curriculum, promote communication and
problem-solving skills, enhance patient assessment
and the delivery of pharmaceutical care.
(Seminar
1) Pre:
fourth year standing or permission of
instructor. Staff
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6.

e.

PHC 517 Interactive Learning Session V (I, 1)
Small group active learning designed to
progressively reinforce the basic science
curriculum, promote communication and
problem-solving skills, and enhance patient
assessment and the delivery of pharmaceutical
care.
(Seminar 1) Pre:
fifth year standing or
permission of instructor. Staff

f.

PHC 527 Interactive Learning Session VI (II, 1)
Small group active learning designed to
progressively reinforce the basic science
curriculum, promote communication and
problem-solving skills, and enhance patient
assessment and the delivery of pharmaceutical
care.
(Seminar 1) Pre:
fifth year standing or
permission of instructor. Staff

g.

PHC 594 Experiential Tracking Practicum (I and II,
7) Through direct hands-on work, students will
learn how to acquire, interpret, and apply
information to extend their knowledge in a
specific field.
This will be accomplished by
collaborative work with a faculty sponsor.
(Practicum 7.5 wks) Pre:
sixth year standing.
Staff

Applied Pharmaceutical Sciences and Pharmacy Practice
a.

APS 404 (or PHP 404) Pharmacokinetics II (II, 3)
Applied pharmacokinetics; therapeutic drug
monitoring, individualization of doses.
(Lee. 3)
Pre:
fourth year standing or permission of
instructor. Rosenbaum and McKindley

b.

APS 515 (or PHP 515) Pharmacy Practice Laboratory
I (I, 1) Simulated practice sessions designed to
develop the delivery of pharmaceutical care,
including prescription processing, use of patient
profiles, communication with patients and health
care professionals, pharmaco-epidemiology, and
physical assessment.
(Lab. 3) Pre:
fifth year
standing or permission of instructor. Cyganoski

c.

APS 516 (or PHP 516) Pharmacy Practice Laboratory
II (II, 1) Simulated practice sessions designed to
develop the delivery of pharmaceutical care,
including prescription pnGcessing, use of patient
profiles, communication with patients and health
ere professionals, pharmaco-epidemiology, and
physical assessment.
(Lab. 3) Pre:
fifth year
standing or permission of instructor. Cyganoski

d.

APS 411 (or ~HP 411 or STA 411) Biostatistics II
(I, 3) An overview of statistical methods used in
performing research in pharmacotherapeutics and
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C.A.C. #360--98-3-31
pharmaco-epidemiology. Emphasis on understanding
both common study designs, and the output from
statistical analysis of data obtained from these
studies.
(Lee. 3) Pre: fourth year standing or
permission of instructor. Dufresne, Heltshe, and
Staff
B.

Delete the following courses:
1)

Department of Applied Pharmaceutical Sciences

a)
b)
c)
d)
e)
f)
g)
h)
i)
j)
k)
2)

last
last
last
last
last
last
last
last
last
last
last

offered
offered
offered
offered
offered
offered
offered
offered
offered
offered
offered

fall 1999
spring 2000
spring 2000
fall 1999
fall 1999
spring 2000
spring 2000
spring 2001
fall 2000
fall 2001
fall 2001

BMS
BMS
BMS
BMS
BMS
BMS
BMS
BMS
BMS
BMS

327
342
343
443
444
446
451
454
455
456

last
last
last
last
last
last
last
last
last
last

offered
offered
offered
offered
offered
offered
offered
offered
offered
offered

fall 1999
spring 2000
fall 1999
fall 2000
spring 2001
fall 2000
spring 2001
spring 2000
fall 2000
spring 2001

Department of Pharmacy Practice
a)
b)
c)
d)
e)
f)

C.

327
328
340
349
350
351
360
448
459
461
462

Department of Biomedical Sciences
a)
b)
c)
d)
e)
f)
g)
h)
i)
j)

3)

APS
APS
APS
APS
APS
APS
APS
APS
APS
APS
APS

PHP
PHP
PHP
PHP
PHP
PHP

455
456
471
484
485
490

last
last
last
last
last
last

offered
offered
offered
offered
offered
offered

fall 2000
spring 2001
fall 2001
spring 2002
spring 2002
spring 2002

Change Curriculum for the Third, Fourth, Fifth and Sixth years:
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Third Year Fall

credits

Third Year Spring

credits

Foundations Human Dis I

PHP!BMS 311

2

Foundations Human Dis II

PHP!BMS
312

2

Principles of Pharmcol.

BMS 321

2

BMS neuro psych

BMS 322

2

Intro to Med Chemistry

BMS 313

2

Pharmacotherapeutics I

PHP 324

2

Physical Pharmacy

APS 314

3

Pharmaceutical Technology

APS 324

3

Biopharmaceutics

APS 315

2

Pharmaceutical Analysis

BMS 325

2

Law&Ethics

APS 316

3

Pharmacy Technology lab

APS 318

MCMIPCOL lab

BMS 326

Interactive Learning *

PHC 317

Interactive Learning

*

PHC 327

university elective

3

16

Fourth Year Fall

16

credits

Fourth Year Spring

credits

Found. of Human Disease III

PHP/BMS
411

2

Found. of Human Disease IV

PHP/BMS
412

3

BMS antiinfectives, pulm

BMS 421

2

BMS endo, GI, biotech

BMS 422

2

Pharmacotherapeutics II

PHP 413

2

Pharmacotherapeutics III

PHP 414

2

Pharmacokinetics I

APS 403

3

Pharmacokinetics II

APS 404

3

Statistics

APS!PHP/STA411

3

professional tracking

MCH/PCOL lab

BMS 416

Interactive Learning •

PHC 417

.~:·

Interactive Learning *

3

PHC 427

14

Fifth Year Fall

credits

14

Fifth Year Spring

credits

Found. of Human Disease VI

PHP/BMS
512

2

BMS oncology, tox

BMS 521

2

BMS cardio, renal

BMS 522

2

Pharmacotherapeutics IV

PHP 513

2

Pharmacotherapeutics V

PHP 514

2

Health Systems I

APS 503

2

Health Systems II

APS 504

3

Self Care I

BMS/PHP 518

3

Nutr in Health & Disease

FSN 444

3

6

professional tracking

professional tracking
Practice Lab
Interactive Learning

*

3

PHP 515

Practice Lab

PHP 516

PHC 517

Interactive Learning *

PHC 527

17
Interactive learning courses will be shared by PHP, BMS, and APS
Sixth Year Fall and Spring
21 credits ofPHP 591, PHP 592, and PHP 593- clinical clerkships (7 credits each)
7 credits of tracking experiential practicum in PHC 594

Total credits required for graduation: 188
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